The Basis for Antiviral Therapy: Drug Targets, Cross-Resistance, and Novel Small Molecule Inhibitors-Reference-Cited by-同舟云学术

The Basis for Antiviral Therapy: Drug Targets, Cross-Resistance, and Novel Small Molecule Inhibitors

Published:2016 Issue: Volume: Page:303-324
ISSN:2197-7852
Container-title:Molecular and Translational Medicine
language:
Short-container-title:

Author:

Revill Peter,Locarnini Stephen

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-22330-8_14

Reference130 articles.

1. Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology. 2007;46(6):1759–68. Epub 2007/11/30.

2. Sureau C, Salisse J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology. 2013;57(3):985–94. Epub 2012/11/20.

3. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife. 2012;1, e00049. Epub 2012/11/15.

4. Li HC, Huang EY, Su PY, Wu SY, Yang CC, Lin YS, et al. Nuclear export and import of human hepatitis B virus capsid protein and particles. PLoS Pathog. 2010;6(10), e1001162. Epub 2010/11/10.

5. Rabe B, Vlachou A, Pante N, Helenius A, Kann M. Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci U S A. 2003;100(17):9849–54. Epub 2003/08/12.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Achieving a Cure: The Next Frontier in Hepatitis B Treatment;Liver Cancer;2021-03-20

2. Role of Hepatitis B virus capsid phosphorylation in nucleocapsid disassembly and covalently closed circular DNA formation;PLOS Pathogens;2020-03-30

3. HIV–HBV and HIV–HCV Coinfection and Liver Cancer Development;Cancer Treatment and Research;2018-12-07